155 related articles for article (PubMed ID: 23581491)
21. Type 2 antidiabetic activity of bergenin from the roots of Caesalpinia digyna Rottler.
Kumar R; Patel DK; Prasad SK; Laloo D; Krishnamurthy S; Hemalatha S
Fitoterapia; 2012 Mar; 83(2):395-401. PubMed ID: 22178680
[TBL] [Abstract][Full Text] [Related]
22. Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advanced glycation end products and oxidative stress in alloxan-induced diabetic rats.
Sefi M; Fetoui H; Makni M; Zeghal N
Food Chem Toxicol; 2010 Jul; 48(7):1986-93. PubMed ID: 20457207
[TBL] [Abstract][Full Text] [Related]
23. Antihyperglycemic and antioxidant effect of hydroethanolic extract of Butea monosperma bark in diabetic mice.
Sharma N; Garg V
Indian J Biochem Biophys; 2012 Feb; 49(1):55-62. PubMed ID: 22435145
[TBL] [Abstract][Full Text] [Related]
24. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
25. Antidiabetic effect of total saponins from Entada phaseoloides (L.) Merr. in type 2 diabetic rats.
Zheng T; Shu G; Yang Z; Mo S; Zhao Y; Mei Z
J Ethnopharmacol; 2012 Feb; 139(3):814-21. PubMed ID: 22212505
[TBL] [Abstract][Full Text] [Related]
26. Design of Multifaceted Antioxidants: Shifting towards Anti-Inflammatory and Antihyperlipidemic Activity.
Tzara A; Lambrinidis G; Kourounakis A
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443516
[TBL] [Abstract][Full Text] [Related]
27. Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation.
Palmer AM; Gopaul N; Dhir S; Thomas CR; Poston L; Tribe RM
Diabetologia; 1998 Feb; 41(2):157-64. PubMed ID: 9498648
[TBL] [Abstract][Full Text] [Related]
28. Potential antidiabetic and hypolipidemic effects of propolis extract in streptozotocin-induced diabetic rats.
El-Sayed el-SM; Abo-Salem OM; Aly HA; Mansour AM
Pak J Pharm Sci; 2009 Apr; 22(2):168-74. PubMed ID: 19339227
[TBL] [Abstract][Full Text] [Related]
29. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents.
Sashidhara KV; Palnati GR; Dodda RP; Sonkar R; Khanna AK; Bhatia G
Eur J Med Chem; 2012 Nov; 57():302-10. PubMed ID: 23078966
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of chitooligosaccharides for the management of diabetes in alloxan induced mice: a correlative study with antihyperlipidemic and antioxidative activity.
Katiyar D; Singh B; Lall AM; Haldar C
Eur J Pharm Sci; 2011 Nov; 44(4):534-43. PubMed ID: 21964204
[TBL] [Abstract][Full Text] [Related]
31. Antioxidative and hypolipidemic efficacy of alcoholic seed extract of Swietenia macrophylla in streptozotocin diabetic rats.
Kalpana K; Pugalendi KV
J Basic Clin Physiol Pharmacol; 2011 Jun; 22(1-2):11-21. PubMed ID: 22865358
[TBL] [Abstract][Full Text] [Related]
32. In vitro antioxidant, antidiabetic and antilipidemic activities of Symplocos cochinchinensis (Lour.) S. Moore bark.
Sunil C; Agastian P; Kumarappan C; Ignacimuthu S
Food Chem Toxicol; 2012 May; 50(5):1547-53. PubMed ID: 22306921
[TBL] [Abstract][Full Text] [Related]
33. Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.
Ladopoulou EM; Matralis AN; Nikitakis A; Kourounakis AP
Bioorg Med Chem; 2015 Nov; 23(21):7015-23. PubMed ID: 26433631
[TBL] [Abstract][Full Text] [Related]
34. Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice.
Bansal P; Paul P; Mudgal J; Nayak PG; Pannakal ST; Priyadarsini KI; Unnikrishnan MK
Exp Toxicol Pathol; 2012 Sep; 64(6):651-8. PubMed ID: 21208790
[TBL] [Abstract][Full Text] [Related]
35. Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents.
Raza S; Srivastava SP; Srivastava DS; Srivastava AK; Haq W; Katti SB
Eur J Med Chem; 2013 May; 63():611-20. PubMed ID: 23567949
[TBL] [Abstract][Full Text] [Related]
36. [The reduction of dyslipidemia and oxidative stress in experimental diabetes mellitus treated with probucol].
Colev V; Păduraru I; Vornicu M; Bădescu M; Mocanu V; Ciocoiu M; Saramet A; Bohotin C
Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):103-7. PubMed ID: 10756736
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological Evaluation of Novel Isonicotinic Carboxamide Derivatives as Potential Anti-Hyperlipidemic and Antioxidant Agents.
Abu Farha R; Bustanji Y; Al-Hiari Y; Bardaweel S; Al-Qirim T; Abu Sheikha G; Albashiti R
Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28837755
[TBL] [Abstract][Full Text] [Related]
38. Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives.
Mokale SN; Elgire RD; Sakle NS; Shinde DB
Arch Pharm (Weinheim); 2012 Jan; 345(1):22-7. PubMed ID: 22076967
[TBL] [Abstract][Full Text] [Related]
39. Antidiabetic and antioxidant effect of various fractions of Phyllanthus simplex in alloxan diabetic rats.
Shabeer J; Srivastava RS; Singh SK
J Ethnopharmacol; 2009 Jul; 124(1):34-8. PubMed ID: 19375496
[TBL] [Abstract][Full Text] [Related]
40. Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis.
Matralis AN; Bavavea EI; Incerpi S; Pedersen JZ; Kourounakis AP
Curr Med Chem; 2017; 24(12):1214-1227. PubMed ID: 27528055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
